Samsung Medical Devices Expand into Treatment Field Through Partnerships with Accuray and HistoSonics
Translated from Korean, summarized and contextualized by DistantNews.
At a glance
- Samsung's medical device division is expanding into therapeutic solutions beyond diagnostics.
- The company has partnered with HistoSonics and now Accuray to develop new treatment technologies.
- This strategic move aims to enhance Samsung's presence in the advanced medical equipment market.
Samsung's medical device business is broadening its scope, moving beyond diagnostic tools to encompass therapeutic applications. Following an earlier collaboration with HistoSonics, a company specializing in non-invasive ultrasound cancer treatment, Samsung has now joined forces with Accuray, a U.S.-based firm focused on radiation surgery.
This partnership with Accuray signifies Samsung's commitment to developing precision imaging-based treatment solutions. The collaboration is expected to leverage Accuray's expertise in advanced radiation therapy systems to create innovative treatment options.
Samsung's Health & Medical Equipment (HME) division is actively pursuing growth in the medical technology sector. By integrating therapeutic capabilities into its portfolio, Samsung aims to offer more comprehensive healthcare solutions and strengthen its competitive position in the global medical device market.
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.